aesica queenborough limited

3

aesica queenborough limited Company Information

Share AESICA QUEENBOROUGH LIMITED
Live 
EstablishedLargeDeclining

Company Number

06350087

Registered Address

aesica queenborough limited, north road, queenborough, kent, ME11 5EL

Industry

Manufacture of basic pharmaceutical products

 

Telephone

01795543000

Next Accounts Due

September 2024

Group Structure

View All

Directors

Thomas Eldered4 Years

Gregor Kawaletz2 Years

View All

Shareholders

consort medical limited 100%

aesica queenborough limited Estimated Valuation

£44.6m

Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £44.6m based on a Turnover of £26.8m and 1.67x industry multiple (adjusted for size and gross margin).

aesica queenborough limited Estimated Valuation

£0

Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £0 based on an EBITDA of £-29.1m and a 7.45x industry multiple (adjusted for size and gross margin).

aesica queenborough limited Estimated Valuation

£35.9m

Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £35.9m based on Net Assets of £15.3m and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Aesica Queenborough Limited Overview

Aesica Queenborough Limited is a live company located in queenborough, ME11 5EL with a Companies House number of 06350087. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in August 2007, it's largest shareholder is consort medical limited with a 100% stake. Aesica Queenborough Limited is a established, large sized company, Pomanda has estimated its turnover at £26.8m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Aesica Queenborough Limited Health Check

Pomanda's financial health check has awarded Aesica Queenborough Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

4 Strong

positive_score

3 Regular

positive_score

5 Weak

size

Size

annual sales of £26.8m, make it in line with the average company (£31.2m)

£26.8m - Aesica Queenborough Limited

£31.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -19%, show it is growing at a slower rate (3.8%)

-19% - Aesica Queenborough Limited

3.8% - Industry AVG

production

Production

with a gross margin of 38.8%, this company has a comparable cost of product (38.5%)

38.8% - Aesica Queenborough Limited

38.5% - Industry AVG

profitability

Profitability

an operating margin of -123.1% make it less profitable than the average company (6.5%)

-123.1% - Aesica Queenborough Limited

6.5% - Industry AVG

employees

Employees

with 277 employees, this is above the industry average (136)

277 - Aesica Queenborough Limited

136 - Industry AVG

paystructure

Pay Structure

on an average salary of £39.4k, the company has a lower pay structure (£58k)

£39.4k - Aesica Queenborough Limited

£58k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £96.8k, this is less efficient (£275.6k)

£96.8k - Aesica Queenborough Limited

£275.6k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 62 days, this is near the average (56 days)

62 days - Aesica Queenborough Limited

56 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 86 days, this is slower than average (40 days)

86 days - Aesica Queenborough Limited

40 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 64 days, this is less than average (98 days)

64 days - Aesica Queenborough Limited

98 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (12 weeks)

1 weeks - Aesica Queenborough Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 56.3%, this is a higher level of debt than the average (46.4%)

56.3% - Aesica Queenborough Limited

46.4% - Industry AVG

AESICA QUEENBOROUGH LIMITED financials

EXPORTms excel logo

Aesica Queenborough Limited's latest turnover from December 2022 is £26.8 million and the company has net assets of £15.3 million. According to their latest financial statements, Aesica Queenborough Limited has 277 employees and maintains cash reserves of £600 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Jan 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover26,800,00035,800,00046,800,00028,800,00049,800,00057,900,00060,700,00065,000,00077,800,00046,900,00040,200,00038,900,00041,900,00041,700,000
Other Income Or Grants00000000000000
Cost Of Sales16,400,00021,374,87328,398,51417,776,15430,035,62334,972,69237,141,15239,475,20549,259,37129,668,55335,500,00032,800,00032,900,00027,900,000
Gross Profit10,400,00014,425,12718,401,48611,023,84619,764,37722,927,30823,558,84825,524,79628,540,62917,231,4474,700,0006,100,0009,000,00013,800,000
Admin Expenses43,400,00019,525,12722,801,48619,523,84633,064,37721,727,30823,358,84812,024,79630,440,62913,731,4473,000,0002,300,0006,000,0008,000,000
Operating Profit-33,000,000-5,100,000-4,400,000-8,500,000-13,300,0001,200,000200,00013,500,000-1,900,0003,500,0001,700,0003,800,0003,000,0005,800,000
Interest Payable400,000800,000900,000500,000600,000500,000500,000400,000500,000300,000300,000300,000100,0000
Interest Receivable0000000000500,000000
Pre-Tax Profit-33,400,000-5,900,000-5,300,000-9,000,000-13,900,000700,000-300,00013,100,0001,300,0003,200,0001,900,0004,000,0002,900,0005,800,000
Tax6,300,0001,900,000900,0001,500,0002,900,000100,000-400,000-1,000,000-1,200,000200,000-300,000-800,000-700,000-1,400,000
Profit After Tax-27,100,000-4,000,000-4,400,000-7,500,000-11,000,000800,000-700,00012,100,000100,0003,400,0001,600,0003,200,0002,200,0004,400,000
Dividends Paid0000000016,500,00005,000,0005,000,00005,000,000
Retained Profit-27,100,000-4,000,000-4,400,000-4,900,000-11,000,000800,000-700,00012,100,000-16,400,0003,400,000-3,400,000-1,800,0002,200,000-600,000
Employee Costs10,900,00012,500,00013,800,00011,500,00016,100,00018,600,00017,200,00018,200,00025,500,00014,300,00013,700,00012,100,00011,500,00011,300,000
Number Of Employees277287369388418457468443429367355356327339
EBITDA*-29,100,000-1,200,000-800,000-5,800,000-6,800,0004,500,0003,200,00016,500,0001,100,0004,800,0002,900,0004,400,0003,300,0006,000,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Jan 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets13,400,00037,900,00037,200,00039,200,00035,700,00036,700,00037,800,00035,600,00033,500,00038,200,00021,400,00016,600,00013,300,0007,000,000
Intangible Assets00000000000000
Investments & Other5,800,000000000004,200,0004,200,0004,200,0004,200,0000
Debtors (Due After 1 year)03,900,0002,400,0002,200,0000000000000
Total Fixed Assets19,200,00034,000,00034,800,00037,000,00035,700,00036,700,00037,800,00035,600,00033,500,00038,200,00021,400,00016,600,00013,300,0007,000,000
Stock & work in progress2,900,0007,200,0008,800,00011,300,00011,200,0006,300,0007,000,0004,400,0005,500,0006,800,0004,200,0003,500,0003,200,0002,900,000
Trade Debtors4,600,0005,300,0005,900,0009,000,00012,300,0009,700,0008,900,0009,200,00010,100,0008,400,0009,300,0008,400,0007,100,0005,300,000
Group Debtors00200,000100,000100,000000000002,600,000
Misc Debtors7,700,0005,300,0005,100,0003,600,0003,200,0001,600,0001,500,0002,300,0001,100,0001,500,0001,200,0001,000,0001,200,0002,000,000
Cash600,0003,200,0003,800,0000400,0002,500,00000000000
misc current assets00000000000200,00000
total current assets15,800,00021,000,00023,800,00024,000,00027,200,00020,100,00017,400,00015,900,00016,700,00016,700,00014,700,00013,100,00011,500,00012,800,000
total assets35,000,00055,000,00058,600,00061,000,00062,900,00056,800,00055,200,00051,500,00050,200,00054,900,00036,100,00029,700,00024,800,00019,800,000
Bank overdraft000000500,000400,0002,100,000300,0002,000,0001,000,00001,900,000
Bank loan00000000000000
Trade Creditors 3,900,0002,900,0004,400,0009,700,00014,900,0008,100,00011,800,0006,200,0004,500,0007,200,0005,200,0004,500,0002,000,0002,800,000
Group/Directors Accounts10,600,0000000000000000
other short term finances0001,100,0000000000000
hp & lease commitments500,000700,000700,000800,0000000000000
other current liabilities2,400,0006,900,00067,500,00057,700,00012,700,0006,100,0008,400,00014,600,00010,500,0008,200,0008,100,0004,900,0007,700,0005,500,000
total current liabilities17,400,00010,500,00072,600,00069,300,00027,600,00014,200,00020,700,00021,200,00017,100,00015,700,00015,300,00010,400,0009,700,00010,200,000
loans000071,800,00032,000,00025,400,00020,400,00029,400,00014,400,0004,200,0004,200,0003,200,0000
hp & lease commitments00000000000000
Accruals and Deferred Income0000000400,0005,800,00010,000,0005,000,000000
other liabilities400,0000000000000000
provisions1,900,0004,200,0005,200,0007,200,0002,400,0002,800,0001,400,000800,0001,800,0002,800,0003,200,0003,400,0003,400,0003,200,000
total long term liabilities2,300,0002,100,0002,600,0003,600,00037,100,00033,400,00026,100,00021,200,00036,100,00025,800,00010,800,0005,900,0004,900,0001,600,000
total liabilities19,700,00012,600,00075,200,00072,900,00064,700,00047,600,00046,800,00042,400,00053,200,00041,500,00026,100,00016,300,00014,600,00011,800,000
net assets15,300,00042,400,000-16,600,000-11,900,000-1,800,0009,200,0008,400,0009,100,000-3,000,00013,400,00010,000,00013,400,00010,200,0008,000,000
total shareholders funds15,300,00042,400,000-16,600,000-11,900,000-1,800,0009,200,0008,400,0009,100,000-3,000,00013,400,00010,000,00013,400,00010,200,0008,000,000
Dec 2022Dec 2021Dec 2020Jan 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit-33,000,000-5,100,000-4,400,000-8,500,000-13,300,0001,200,000200,00013,500,000-1,900,0003,500,0001,700,0003,800,0003,000,0005,800,000
Depreciation3,900,0003,900,0003,600,0002,700,0006,500,0003,300,0003,000,0003,000,0003,000,0001,300,0001,200,000600,000300,000200,000
Amortisation00000000000000
Tax6,300,0001,900,000900,0001,500,0002,900,000100,000-400,000-1,000,000-1,200,000200,000-300,000-800,000-700,000-1,400,000
Stock-4,300,000-1,600,000-2,400,000100,0004,900,000-700,0002,600,000-1,100,0005,500,0002,600,000700,000300,000300,0002,900,000
Debtors-2,200,000900,000-2,000,000-700,0004,300,000900,000-1,100,000300,00011,200,000-600,0001,100,0001,100,000-1,600,0009,900,000
Creditors1,000,000-1,500,000-10,500,000-5,200,0006,800,000-3,700,0005,600,0001,700,0004,500,0002,000,000700,0002,500,000-800,0002,800,000
Accruals and Deferred Income-4,500,000-60,600,00054,800,00045,000,0006,600,000-2,300,000-6,600,000-1,300,00016,300,0005,100,0008,200,000-2,800,0002,200,0005,500,000
Deferred Taxes & Provisions-2,300,000-1,000,0002,800,0004,800,000-400,0001,400,000600,000-1,000,0001,800,000-400,000-200,0000200,0003,200,000
Cash flow from operations-22,100,000-61,700,00051,600,00040,900,000-100,000-200,000900,00015,700,0005,800,0009,700,0009,500,0001,900,0005,500,0003,300,000
Investing Activities
capital expenditure20,600,000-4,600,000-5,100,000-6,200,000-5,500,000-2,200,000-5,200,000-5,100,000-36,500,000-18,100,000-6,000,000-3,900,000-6,600,000-7,200,000
Change in Investments5,800,000000000000004,200,0000
cash flow from investments14,800,000-4,600,000-5,100,000-6,200,000-5,500,000-2,200,000-5,200,000-5,100,000-36,500,000-18,100,000-6,000,000-3,900,000-10,800,000-7,200,000
Financing Activities
Bank loans00000000000000
Group/Directors Accounts10,600,0000000000000000
Other Short Term Loans 0001,100,0000000000000
Long term loans00-71,800,000-71,800,00039,800,0006,600,0005,000,000-9,000,00029,400,00010,200,00001,000,0003,200,0000
Hire Purchase and Lease Commitments-200,0000700,000800,0000000000000
other long term liabilities400,0000000000000000
share issue063,000,000-10,400,000-5,200,000000013,400,000005,000,00008,600,000
interest-400,000-800,000-900,000-500,000-600,000-500,000-500,000-400,000-500,000-300,000200,000-300,000-100,0000
cash flow from financing10,400,00062,200,000-82,400,000-75,600,00039,200,0006,100,0004,500,000-9,400,00042,300,0009,900,000200,0005,700,0003,100,0008,600,000
cash and cash equivalents
cash-2,600,000-600,0003,400,000-400,000-2,100,0002,500,00000000000
overdraft00000-500,000100,000-1,700,0002,100,000-1,700,0001,000,0001,000,000-1,900,0001,900,000
change in cash-2,600,000-600,0003,400,000-400,000-2,100,0003,000,000-100,0001,700,000-2,100,0001,700,000-1,000,000-1,000,0001,900,000-1,900,000

aesica queenborough limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for aesica queenborough limited. Get real-time insights into aesica queenborough limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Aesica Queenborough Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for aesica queenborough limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

aesica queenborough limited Ownership

AESICA QUEENBOROUGH LIMITED group structure

Aesica Queenborough Limited has 1 subsidiary company.

Ultimate parent company

RECIPHARM AB (PUBL)

#0085293

2 parents

AESICA QUEENBOROUGH LIMITED

06350087

1 subsidiary

AESICA QUEENBOROUGH LIMITED Shareholders

consort medical limited 100%

aesica queenborough limited directors

Aesica Queenborough Limited currently has 4 directors. The longest serving directors include Mr Thomas Eldered (Feb 2020) and Mr Gregor Kawaletz (May 2022).

officercountryagestartendrole
Mr Thomas ElderedSweden63 years Feb 2020- Director
Mr Gregor KawaletzEngland57 years May 2022- Director
Mr Andrew DawsonEngland44 years Feb 2023- Director
Mr Emmanuel GrandEngland50 years Apr 2024- Director

P&L

December 2022

turnover

26.8m

-25%

operating profit

-33m

+547%

gross margin

38.9%

%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

15.3m

-0.64%

total assets

35m

-0.36%

cash

600k

-0.81%

net assets

Total assets minus all liabilities

aesica queenborough limited company details

company number

06350087

Type

Private limited with Share Capital

industry

21100 - Manufacture of basic pharmaceutical products

incorporation date

August 2007

age

17

accounts

Full Accounts

ultimate parent company

RECIPHARM AB (PUBL)

previous names

N/A

incorporated

UK

address

aesica queenborough limited, north road, queenborough, kent, ME11 5EL

last accounts submitted

December 2022

aesica queenborough limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 10 charges/mortgages relating to aesica queenborough limited. Currently there are 2 open charges and 8 have been satisfied in the past.

charges

aesica queenborough limited Companies House Filings - See Documents

datedescriptionview/download